We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CLSN market cap is 18.42M. The company's latest EPS is USD -2.0763 and P/E is -0.54.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 125k | 125k | 0 | 0 | 0 |
| Operating Income | -6.18M | -20.29M | -5.68M | -5.48M | -3.9M |
| Net Income | -6.15M | -13.23M | -5.59M | -5.56M | -3.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 500k | 500k | 502k | 500k | 0 |
| Operating Income | -20.57M | -20.86M | -22.98M | -38.29M | -21.03M |
| Net Income | -16.85M | -21.48M | -20.77M | -35.9M | -19.52M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 60.53M | 43.98M | 42.11M | 28.72M | 24.65M |
| Total Liabilities | 19.18M | 14.65M | 15.46M | 7.21M | 6.58M |
| Total Equity | 41.35M | 29.33M | 26.65M | 21.52M | 18.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.28M | 37.53M | 74.05M | 43.98M | 21.92M |
| Total Liabilities | 23.72M | 18.92M | 18.25M | 14.65M | 8.53M |
| Total Equity | 14.56M | 18.61M | 55.8M | 29.33M | 13.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.07M | -23.13M | -4.09M | -10.78M | -15.25M |
| Investing | 19.15M | 8.32M | 519k | 3.64M | 14.31M |
| Financing | 6.28M | 6.72M | 2.47M | -3.75M | -3.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.26M | -15.62M | -16.22M | -23.13M | -19.02M |
| Investing | 5.94M | 7.92M | -30.12M | 8.32M | 11.01M |
| Financing | 7.84M | 17.98M | 54.77M | 6.72M | -3.64M |
| Market Cap | 18.42M |
| Price to Earnings Ratio | -0.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.8 |
| Price to Book Ratio | 0.79 |
| Dividend Yield | - |
| Shares Outstanding | 9.4M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (4.85%) |
| Company Name | Celsion Corporation |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.imunon.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
